Childhood Embryonal Tumor
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Embryonal Tumor trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Embryonal Tumor trials you may qualify forThe phase I portion of this study is designed for children or adolescents and young adults (AYA) with a diagnosis of a solid tumor that has recurred (come back…
This research study is evaluating a therapy called proton beam radiation therapy (PBRT) as a possible treatment for neuroblastoma. Neuroblastoma most commonly…
This phase I clinical trial studies the side effects and best dose of AZD1390 and to see how well it works when given together with radiation therapy for the tr…
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is re…
This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with soli…
This phase I trial investigates the side effects and determines the best dose of an immune cell therapy called GD2CART, as well as how well it works in treating…